Antibacterial Pipeline

 

Novel Vaccines and therapeutics against bacterial infections

Discovery
Early Preclinical
IND-enabling
IND
Phase I
Phase II
Phase III
Product Description Details

STEBVax

Toxoid vaccine against S. aureus Enterotoxin B (SEB)

Rationally designed SEB-toxoid vaccine for prevention of toxic shock syndrome

 
Discovery
Early Preclinical
IND-enabling
IND
Phase I

IBT-V02

Multivalent toxoid vaccine against Staphylococcus aureus infections

Rationally designed 5-component toxoid vaccine against pore-forming toxins and superantigens for prevention of S. aureus skin and skin structure infections (SSSI)

 
Discovery
Early Preclinical
IND-enabling

Cd-ISTAb

ISTAb against Clostridium difficile infection

ISTAb, neutralizing antibody cocktail against TcdA and TcdB engineered to target to the surface of C. difficile to achieve both neutralization and bacterial clearance for treatment of CDI.

 
Discovery
Early Preclinical

Ba-ISTAb

ISTAb against Bacillus anthracis

ISTAb, an anti-PA neutralizing antibody targeted to the surface of B. anthracis to achieve both neutralization and bacterial clearance for treatment of Inhalation Anthrax.

 
Discovery
Early Preclinical

Contact us for more information    Contact IBT